Arch Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arch Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2012 to Q1 2024.
  • Arch Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $592K, a 6.74% decline year-over-year.
  • Arch Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.72M, a 126% increase year-over-year.
  • Arch Therapeutics, Inc. annual Interest Expense for 2023 was $3.1M, a 446% increase from 2022.
  • Arch Therapeutics, Inc. annual Interest Expense for 2022 was $567K, a 277% increase from 2021.
  • Arch Therapeutics, Inc. annual Interest Expense for 2021 was $151K, a 712% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.72M $592K -$42.8K -6.74% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.76M $1.19M +$663K +126% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $3.1M $1.13M +$681K +152% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-15
Q2 2023 $2.42M $809K +$769K +1928% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.65M $635K +$596K +1510% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.05M $524K +$484K +1200% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 $567K $447K +$407K +1009% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-15
Q2 2022 $160K $39.9K -$296 -0.74% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $160K $39.5K -$1.3K -3.19% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 $162K $40.3K +$11.1K +37.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $151K $40.3K Jul 1, 2021 Sep 30, 2021 10-K 2022-12-28
Q2 2021 $40.2K +$36K +851% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $40.8K +$40.8K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $29.3K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q2 2020 $4.23K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2018 $0 $0 $0 Jul 1, 2018 Sep 30, 2018 10-K 2018-12-18
Q2 2018 $0 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $0 $0 -$26.8K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2018-04-26
Q4 2017 $26.8K $0 -$25.6K -100% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-01
Q3 2017 $52.4K $0 -$33K -100% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-18
Q2 2017 $85.4K $0 -$33.1K -100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $119K $26.8K -$40K -59.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $159K $25.6K -$118K -82.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q3 2016 $277K $33K -$132K -80% Jul 1, 2016 Sep 30, 2016 10-K 2017-11-15
Q2 2016 $409K $33.1K -$101K -75.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $510K $66.8K +$16.3K +32.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $494K $144K +$116K +418% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-01
Q3 2015 $378K $165K +$137K +495% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-05
Q2 2015 $240K $134K +$107K +384% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $134K $50.6K +$22.8K +82.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $111K $27.8K $0 0% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 $111K $27.8K +$27.3K +5476% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-11
Q2 2014 $83.8K $27.8K +$8.17K +41.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $75.6K $27.8K -$18K -39.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $93.7K $27.8K -$15.2K -35.4% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $109K $498 Jul 1, 2013 Sep 30, 2013 10-K 2014-12-12
Q2 2013 $19.6K -$19.6K -50.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $45.8K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $43K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q2 2012 $39.2K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.